These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 8205084

  • 21. Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
    Subirà M, Sureda A, Martino R, García J, Altés A, Canals C, Domingo-Albós A, Brunet S, Sierra J.
    Haematologica; 2000 Feb; 85(2):167-72. PubMed ID: 10681724
    [Abstract] [Full Text] [Related]

  • 22. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM, Honegger HP, Stahel RA.
    Schweiz Med Wochenschr; 2000 Jan 22; 130(3):60-9. PubMed ID: 10683881
    [Abstract] [Full Text] [Related]

  • 23. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 22; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 24. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb 22; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 25. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
    Stockerl-Goldstein KE, Horning SJ, Negrin RS, Chao NJ, Hu WW, Long GD, Hoppe RT, Amylon MD, Brown BW, Wong RM, Blume KG.
    Biol Blood Marrow Transplant; 1996 May 22; 2(2):76-85. PubMed ID: 9118302
    [Abstract] [Full Text] [Related]

  • 26. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO.
    Bone Marrow Transplant; 2003 Apr 22; 31(7):559-64. PubMed ID: 12692621
    [Abstract] [Full Text] [Related]

  • 27. High-dose cytotoxic therapy with autologous bone marrow or peripheral blood progenitor cell transplantation in malignant lymphomas.
    Cucuianu A, D'Hondt L, Collignon J, Verhulst D, Deprijck B, Chatelain C, Doyen C, Bosly A.
    Rom J Intern Med; 1995 Apr 22; 33(3-4):211-25. PubMed ID: 8646194
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of moderate-grade and high-grade malignant lymphoma with autologous hematopoietic stem cell transplantation].
    Wang AL, He ZD, Luo Y, Xiao LX, Liu XY, Zhu YH.
    Ai Zheng; 2003 Dec 22; 22(12):1317-20. PubMed ID: 14693059
    [Abstract] [Full Text] [Related]

  • 29. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J, Powles R, Singhal S, Horton C, Tait D, Treleaven J.
    Bone Marrow Transplant; 1996 Jul 22; 18(1):119-23. PubMed ID: 8832004
    [Abstract] [Full Text] [Related]

  • 30. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F, Italian Pediatric Group for Bone Marrow Transplantation.
    Bone Marrow Transplant; 2001 Jul 22; 28(2):131-6. PubMed ID: 11509930
    [Abstract] [Full Text] [Related]

  • 31. Long-term disease-free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation.
    Toze CL, Barnett MJ, Connors JM, Gascoyne RD, Voss NJ, Nantel SH, Nevill TJ, Shepherd JD, Sutherland HJ, Lavoie JC, Forrest DL, Song KW, Hogge DE.
    Br J Haematol; 2004 Nov 22; 127(3):311-21. PubMed ID: 15491292
    [Abstract] [Full Text] [Related]

  • 32. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, Fruehauf S, Ho AD.
    Stem Cells; 2007 Jan 22; 25(1):228-35. PubMed ID: 17204607
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT).
    Voso MT, Martin S, Hohaus S, Abdallah A, Schlenk RF, Ho AD, Haas R.
    Bone Marrow Transplant; 2000 May 22; 25(9):957-64. PubMed ID: 10800063
    [Abstract] [Full Text] [Related]

  • 34. Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group.
    Sureda A, Mataix R, Hernández-Navarro F, Jarque I, Lahuerta JJ, Tomás JF, Brunet S, Caballero D, Conde E, León A, Fernández MN, López A, Maldonado J, Bengoechea E, Callís M, Carrera D, García-Conde J, García-Laraña J, Moraleda JM, Morey M, Rifón J, Sierra J, Torres A, Domingo-Albós A.
    Bone Marrow Transplant; 1997 Aug 22; 20(4):283-8. PubMed ID: 9285542
    [Abstract] [Full Text] [Related]

  • 35. Autologous bone marrow/stem cell transplantation: initial experience at a north Indian referral centre.
    Gupta S, Kumar L, Raju GM, Kochupillai V, Shukla DK.
    Natl Med J India; 2000 Aug 22; 13(2):61-6. PubMed ID: 10835851
    [Abstract] [Full Text] [Related]

  • 36. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E, Klingebiel TH, Peters C, Hermann J, Burdach ST, Bender-Götze C, Müller-Weihrich ST, Treuner J.
    Bone Marrow Transplant; 1997 Feb 22; 19(3):227-31. PubMed ID: 9028550
    [Abstract] [Full Text] [Related]

  • 37. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P.
    Biol Blood Marrow Transplant; 1997 Oct 22; 3(4):217-23. PubMed ID: 9360784
    [Abstract] [Full Text] [Related]

  • 38. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
    Hänel M, Kröger N, Sonnenberg S, Bornhäuser M, Krüger W, Kroschinsky F, Hänel A, Metzner B, Birkmann J, Schmid B, Hoffknecht MM, Fiedler F, Ehninger G, Zander AR.
    Ann Hematol; 2002 Feb 22; 81(2):96-102. PubMed ID: 11907790
    [Abstract] [Full Text] [Related]

  • 39. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B, Kowalczyk JR, Chybicka A, Wachowiak J, Drabko K, Zaucha-Prazmo A, Choma M, Gorczyńska E, Toporski J, Turkiewicz D, Kałwak K, Pieczonka A, Boruczkowski D.
    Przegl Lek; 2004 Feb 22; 61 Suppl 2():53-6. PubMed ID: 15686047
    [Abstract] [Full Text] [Related]

  • 40. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M, van Besien KW, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE.
    Bone Marrow Transplant; 1997 Jan 22; 19(2):121-7. PubMed ID: 9116608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.